India's COVID-19 caseload went past 92 lakh with 44,376 new cases reported in a day, while the number of recoveries surged to 86.42 lakh, the health ministry said on Wednesday.
The number of total coronavirus cases rose to 92,22,216 in the country, while the death toll due to the disease climbed to 1,34,699 with 481 new fatalities, the ministry's data updated at 8 am showed.
The active caseload shot up to4,44,746, an increase of 6,079 cases from Tuesday, even though it remained below five lakh for the 15th consecutive day, accounting for 4.82 per cent of the total cases, the data stated.
The number of people who have recuperated from the disease surged to 86,42,771, pushing the national recovery rate to93.72per cent, while the COVID-19casefatality rate stands at 1.46 per cent.
India's COVID-19 tally had crossed the 20-lakh mark on August 7, 30-lakh mark on August 23 and 40-lakh mark on September 5.
Frequently Asked Questions
A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.
There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.
Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
It went past 50 lakh on September 16,60 lakh on September 28, 70 lakh on October 11, 80 lakh on October 29 and 90 lakh on November 20.
According to the Indian Council of Medical Research (ICMR), over13.48 crore samples were tested for COVID-19 up to November 24, including 11,59,032on Tuesday.